23andMe sold the rights to a drug it developed from its genetic database
The genetics testing company 23andMe licensed the rights to a drug it developed in-house to a Spanish pharmaceutical company, Bloomberg reported. This is the first time that the company has directly sold a product it created using the genetic information collected from users.
Continue Reading https://www.theverge.com
Join the Discussion